
|Articles|May 27, 2004
AUA: Post-marketing studies of ED therapies are under review
The latest update of AUA guidelines for management of organic erectile dysfunction will focus on novel treatment recommendations and suggestions for study designs that minimize conflicts of interest in post-marketing comparisons of oral drug therapies.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Trial launches of neuromodulation therapy for erectile dysfunction after radical prostatectomy
2
PROSTOX ultra launches on US market following new data presented at ASTRO 2025
3
Rectal diazepam eases instillation of nadofaragene firadenovec in NMIBC
4
Published data show benefit of niraparib with AAP in HRR-deficient mCSPC
5